Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer
Despite major medical advances in recent decades, colorectal cancer remains a major public health problem with significant unmet medical needs. This reprint presents new scientific and clinical data, and discusses the need to identify new theranostic biomarkers from tissue and fluid biopsies, to go...
Format: | eBook |
---|---|
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
LEADER | 03320namaa2200973uu 4500 | ||
---|---|---|---|
001 | doab98158 | ||
003 | oapen | ||
005 | 20230307 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 230307s2023 xx |||||o ||| 0|eng d | ||
020 | |a 9783036568362 | ||
020 | |a 9783036568379 | ||
020 | |a books978-3-0365-6836-2 | ||
024 | 7 | |a 10.3390/books978-3-0365-6836-2 |2 doi | |
040 | |a oapen |c oapen | ||
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a K |2 bicssc | |
720 | 1 | |a Dedieu, Stephane |4 edt | |
720 | 1 | |a Dedieu, Stephane |4 oth | |
245 | 0 | 0 | |a Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 online resource (206 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
520 | |a Despite major medical advances in recent decades, colorectal cancer remains a major public health problem with significant unmet medical needs. This reprint presents new scientific and clinical data, and discusses the need to identify new theranostic biomarkers from tissue and fluid biopsies, to go further in terms of personalised medicine and thus overcome current limitations. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Economics, Finance, Business and Management |2 bicssc | |
653 | |a ablation | ||
653 | |a ACKR3 | ||
653 | |a adjuvant | ||
653 | |a chemokine | ||
653 | |a chemotherapy | ||
653 | |a circulating tumor cells | ||
653 | |a CMS | ||
653 | |a colon cancer | ||
653 | |a colonic neoplasms | ||
653 | |a colorectal cancer | ||
653 | |a discoidin domain receptor | ||
653 | |a dual expression | ||
653 | |a early recurrence | ||
653 | |a epigenetics | ||
653 | |a ERBB2 | ||
653 | |a event free survival | ||
653 | |a extracellular vesicles | ||
653 | |a genome-wide association study | ||
653 | |a HER-2 | ||
653 | |a heterogeneity | ||
653 | |a high-definition single-cell assay | ||
653 | |a liquid biopsy | ||
653 | |a liver metastases | ||
653 | |a lung metastases | ||
653 | |a Lynch Syndrome | ||
653 | |a Mendelian randomization | ||
653 | |a metastasis | ||
653 | |a microenvironment | ||
653 | |a mismatch repair proteins | ||
653 | |a multi-assay | ||
653 | |a n/a | ||
653 | |a oncosomes | ||
653 | |a PD-L1 | ||
653 | |a polygenic risk scores | ||
653 | |a poor prognosis | ||
653 | |a pre-metastatic niche | ||
653 | |a precision medicine | ||
653 | |a prognosis | ||
653 | |a protein biomarker | ||
653 | |a rare cell | ||
653 | |a RAS mutations | ||
653 | |a resection | ||
653 | |a resistance | ||
653 | |a signaling pathways | ||
653 | |a Snail transcription factor | ||
653 | |a surgery | ||
653 | |a survival | ||
653 | |a therapy | ||
653 | |a tumor budding | ||
793 | 0 | |a DOAB Library. | |
856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/98158 |7 0 |z Open Access: DOAB: description of the publication |
856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/6931 |7 0 |z Open Access: DOAB, download the publication |